The hard clinical context related to the age-related macular degeneration or maculopathy, chronic ocular disease and first cause of blindness in developed countries, has to be solved. The number of affected patients is increasing drastically with 500'000 new cases per year and a pool of 260 million patients is estimated for 2040. Despite the noted efficacy of the drug, the intravitreal injections to which patients are subjected monthly implies a high rate of treatment dropout, followed by a very high risk of irreversible blindness condition. ____________________________________________________________ MgShell is developing an innovative game changer in the treatment space, an intraocular device able to replicate the current clinical strategy reducing drastically the number of intravitreal injections and all the therapeutical burdens. Our device represents the only technological solution able to replicate the current clinical practice with a single injection and release the same therapeutical drug doses in preset times, in an autonomous way and without surgical procedures. We offer a product as a result of a win-win-win philosophy: we do compliance for affected patients, we do decrease of overheads for Healthcare systems, and we do business for pharmaceutical companies.
| Website | http://www.mgshell.com |
| Employees | 11 (4 on RocketReach) |
| Founded | 2019 |
| Address | Piazza Leonardo da Vinci, 32, Milano, Lombardia 20133, IT |
| Phone | +39 349 372 9028 |
| Industry | Medical Equipment Manufacturing, Biotechnology, Pharmaceuticals |
| Keywords | Macular Degeneration, Age Related Macular Degeneration, Ophthalmology, Retinal Diseases, Amd Treatment, Eye Care, Ocular Disease, Vision Loss, Eye Health, Ocular Health, Blindness, Eye Research, Clinical Trials, Ophthalmic Devices, Vision Science, Medical Technology, Biotechnology, Pharmaceutical, Drug Development |
| Competitors | Shell, ExxonMobil, bp, Chevron, TotalEnergies, ConocoPhillips, Equinor, Eni, Suncor, Repsol +37 more (view full list) |
Looking for a particular MgShell S.r.l. employee's phone or email?
Marco Ferroni is the Chairman, CEO and Co-founder of MgShell S.r.l..
4 people are employed at MgShell S.r.l..
MgShell S.r.l. is based in Milano, Lombardia.